In vivo molecular imaging using nanomaterials: General in vivo characteristics of nano-sized reagents and applications for cancer diagnosis (Review)

References

• Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. 2009. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 61:428–437.
   PubMed Web of Science ®Google Scholar
• Akerman ME, Chan WCW, Laakkonen P, Bhatia SN, Ruoslahti E. 2002. Nanocrystal targeting in vivo. Proc Natl Acad Sci USA 99:12617–12621.
   PubMed Web of Science ®Google Scholar
• Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, Read EJ, Frank JA. 2004. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104:1217–1223.
   PubMed Web of Science ®Google Scholar
• Ballou B, Ernst LA, Andreko S, Harper T, Fitzpatrick JAJ, Waggoner AS, Bruchez MP. 2007. Sentinel lymph node imaging using quantum dots in mouse tumor models. Bioconj Chem 18:389–396.
   PubMed Web of Science ®Google Scholar
• Barrett T, Ravizzini G, Choyke PL, Kobayashi H. 2009. Dendrimers in medical nanotechnology application of dendrimer molecules in bioimaging and cancer treatment. IEEE Eng Med Biol Mag 28:12–22.
   PubMed Web of Science ®Google Scholar
• Bulte JWM, Kraitchman DL. 2004. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17:484–499.
   PubMed Web of Science ®Google Scholar
• Cai WB, Hsu AR, Li ZB, Chen XY. 2007. Are quantum dots ready for in vivo imaging in human subjects? Nanoscale Res Lett 2:265–281.
   PubMed Web of Science ®Google Scholar
• Chatteriee DK, Rufalhah AJ, Zhang Y. 2008a. Upconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystals. Biomaterials 29:937–943.
   PubMedGoogle Scholar
• Chatterjee DK, Fong LS, Zhang Y. 2008b. Nanoparticles in photodynamic therapy: An emerging paradigm. Adv Drug Deliv Rev 60:1627–1637.
   PubMed Web of Science ®Google Scholar
• Choi HS, Liu W, Liu F, Nasr K, Misra P, Bawendi MG, Frangioni JV. 2010. Design considerations for tumour-targeted nanoparticles. Nat Nanotechnol 5:42–47.
   PubMed Web of Science ®Google Scholar
• Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Ipe BI, Bawendi MG, Frangioni JV. 2007. Renal clearance of quantum dots. Nature Biotechnol 25:1165–1170.
   PubMed Web of Science ®Google Scholar
• Corot C, Robert P, Idee JM, Port M. 2006. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 58:1471–1504.
   PubMed Web of Science ®Google Scholar
• Delehanty JB, Boeneman K, Bradburne CE, Robertson K, Medintz IL. 2009. Quantum dots: A powerful tool for understanding the intricacies of nanoparticle-mediated drug delivery. Expert Opin Drug Deliv 6:1091–112.
   PubMed Web of Science ®Google Scholar
• Duncan R, Izzo L. 2005. Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev 57:2215–2237.
   PubMed Web of Science ®Google Scholar
• Efros AL. 1982. Interband absorption of light in a semiconductor sphere. Sov Phys Semiconductors-USSR 16:772–775.
   Web of Science ®Google Scholar
• Frangioni JV, Hajjar RJ. 2004. In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation 110:3378–3383.
   PubMed Web of Science ®Google Scholar
• Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R. 2003. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348:2491–2499.
   PubMed Web of Science ®Google Scholar
• Hayashi K, Jiang P, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Moossa AR, Bouvet M, Hoffman RM. 2007. Real-time imaging of tumor-cell shedding and trafficking in lymphatic channels. Cancer Res 67:8223–8228.
   PubMedGoogle Scholar
• Hezinger AFE, Tessmar J, Gopferich A. 2008. Polymer coating of quantum dots – a powerful tool toward diagnostics and sensorics. Eur J Pharmaceut Biopharmaceut 68:138–152.
   PubMed Web of Science ®Google Scholar
• Jain R, Dandekar P, Patravale V. 2009. Diagnostic nanocarriers for sentinel lymph node imaging. J Controlled Release 138:90–102.
   PubMed Web of Science ®Google Scholar
• Jaiswal JK, Mattoussi H, Mauro JM, Simon SM. 2003. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nature Biotechnol 21:47–51.
   PubMed Web of Science ®Google Scholar
• Jalil RA, Zhang Y. 2008. Biocompatibility of silica coated NaYF4 upconversion fluorescent nanocrystals. Biomaterials 29:4122–4128.
   PubMed Web of Science ®Google Scholar
• Jamieson T, Bakhshi R, Petrova D, Pocock R, Imani M, Seifalian AM. 2007. Biological applications of quantum dots. Biomaterials 28:4717–4732.
   PubMed Web of Science ®Google Scholar
• Kaminskas LM, Boyd BJ, Karellas P, Krippner GY, Lessene R, Kelly B, Porter CJH. 2008. The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly L-lysine dendrimers. Molec Pharmaceut 5:449–463.
   PubMed Web of Science ®Google Scholar
• Kim S, Fisher B, Eisler HJ, Bawendi M. 2003. Type-II quantum dots: CdTe/CdSe(core/shell) and CdSe/ZinTe(core/shell) heterostructures. J Am Chem Soc 125:11466–11467.
   PubMed Web of Science ®Google Scholar
• Kim S, Lim YT, Soltesz EG, De Grand AM, Lee J, Nakayama A, Parker JA, Mihaljevic T, Laurence RG, Dor DM, Cohn LH, Bawendi MG, Frangioni JV. 2004. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nature Biotechnol 22:93–97.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Brechbiel MW. 2003. Dendrimer-based macromolecular MRI contrast agents: Characteristics and application. Molec Imag 2:1–10.
   PubMedGoogle Scholar
• Kobayashi H, Brechbiel MW. 2004. Dendrimer-based nanosized MRI contrast agents. Curr Pharmaceut Biotechnol 5:539–549.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Brechbiel MW. 2005. Nano-sized MRI contrast agents with dendrimer cores. Adv Drug Deliv Rev 57:2271–2286.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Hama Y, Koyama Y, Barrett T, Regino CAS, Urano Y, Choyke PL. 2007a. Simultaneous multicolor imaging of five different lymphatic basins using quantum dots. Nano Lett 7:1711–1716.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Jo SK, Kawamoto S, Yasuda H, Hu XZ, Knopp MV, Brechbiel MW, Choyke PL, Star RA. 2004a. Polyamine dendrimer-based MRI contrast agents for functional kidney imaging to diagnose acute renal failure. J Magnet Res Imag 20:512–518.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Kawamoto S, Bernardo M, Brechbiel MW, Knopp MV, Choyke PL. 2006. Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: Comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging. J Controlled Release 111:343–351.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Kawamoto S, Brechbiel MW, Bernardo M, Sato N, Waldmann TA, Tagaya Y, Choyke PL. 2005. Detection of lymph node involvement in hematologic malignancies using micromagnetic resonance lymphangiography with a gadolinum-labeled dendrimer nanoparticle. Neoplasia 7:984–991.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Kawamoto S, Jo SK, Bryant HL, Brechbiel MW, Star RA. 2003a. Macromolecular MRI contrast agents with small dendrimers: Pharmacokinetic differences between sizes and cores. Bioconj Chem 14:388–394.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Kawamoto S, Saga T, Sato N, Hiraga A, Ishimori T, Konishi J, Togashi K, Brechbiel MW. 2001a. Positive effects of polyethylene glycol conjugation to generation-4 polyamidoamine dendrimers as macromolecular MR contrast agents. Magnet Reson Med 46:781–788.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Kawamoto S, Sakai Y, Choyke PL, Star RA, Brechbiel MW, Sato N, Tagaya Y, Morris JC, Waldmann TA. 2004b. Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. J Nat Cancer Inst 96:703–708.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Kawamoto S, Star RA, Waldmann TA, Tagaya Y, Brechbiel MW. 2003b. Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent. Cancer Res 63:271–276.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Kosaka N, Ogawa M, Morgan NY, Smith PD, Murray CB, Ye XC, Collins J, Kumar GA, Bell H, Choyke PL. 2009. In vivo multiple color lymphatic imaging using upconverting nanocrystals. J Materials Chem 19:6481–6484.
   Google Scholar
• Kobayashi H, Koyama Y, Barrett T, Hama Y, Regino CAS, Shin IS, Jang BS, Le N, Paik CH, Choyke PL, Urano Y. 2007b. Multimodal nanoprobes for radionuclide and five-color near-infrared optical lymphatic imaging. Acs Nano 1:258–264.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Saga T, Kawamoto S, Sato N, Hiraga A, Ishimori T, Konishi J, Togashi K, Brechbiel MW. 2001b. Dynamic micro-magnetic resonance imaging of liver micrometastasis in mice with a novel liver macromolecular magnetic resonance contrast agent DAB-Am64-(1B4M-Gd)(64). Cancer Res 61:4966–4970.
   PubMed Web of Science ®Google Scholar
• Kojima C, Kono K, Maruyama K, Takagishi T. 2000. Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconj Chem 11:910–917.
   PubMed Web of Science ®Google Scholar
• Kosaka N, Ogawa M, Sato N, Choyke PL, Kobayashi H. 2009. In vivo real-time, multicolor, quantum dot lymphatic imaging. J Invest Dermatol 129:2818–2822.
   PubMed Web of Science ®Google Scholar
• Lim J, Guo Y, Rostollan CL, Stanfield J, Hsieh JT, Sun XK, Simanek EE. 2008. The role of the size and number of polyethylene glycol chains in the biodistribution and tumor localization of triazine dendrimers. Molec Pharmaceut 5:540–547.
   PubMed Web of Science ®Google Scholar
• Lin SP, Brown JJ. 2007. MR contrast agents: Physical and pharmacologic basics. J Magnet Reson Imag 25:884–899.
   PubMed Web of Science ®Google Scholar
• Margolis DJA, Hoffman JM, Herfkens RJ, Jeffrey RB, Quon A, Gambhir SS. 2007. Molecular imaging techniques in body imaging. Radiology 245:333–356.
   PubMedGoogle Scholar
• Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. 2005. Quantum dot bioconjugates for imaging, labelling and sensing. Nature Materials 4:435–446.
   PubMed Web of Science ®Google Scholar
• Moore A, Sun PZ, Cory D, Hogemann D, Weissleder R, Lipes MA. 2002. MRI of insulitis in autoimmune diabetes. Magn Reson Med 47:751–758.
   PubMedGoogle Scholar
• Pelley JL, Daar AS, Saner MA. 2009. State of academic knowledge on toxicity and biological fate of quantum dots. Toxicolog Sci 112:276–296.
   PubMed Web of Science ®Google Scholar
• Rogers WJ, Meyer CH, Kramer CM. 2006. Technology insight: In vivo cell tracking by use of MRI. Nature Clin Pract Cardiovasc Med 3:554–562.
   PubMedGoogle Scholar
• Rzigalinski BA, Strobl JS. 2009. Cadmium-containing nanoparticles: Perspectives on pharmacology and toxicology of quantum dots. Toxicol Appl Pharmacol 238:280–288.
   PubMed Web of Science ®Google Scholar
• Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, Koretsky AP. 2004. MRI detection of single particles for cellular imaging. Proc Natl Acad Sci USA 101:10901–10906.
   PubMed Web of Science ®Google Scholar
• Smith AM, Dave S, Nie SM, True L, Gao XH. 2006. Multicolor quantum dots for molecular diagnostics of cancer. Exp Rev Molec Diagnost 6:231–244.
   PubMed Web of Science ®Google Scholar
• Smith AM, Duan HW, Mohs AM, Nie SM. 2008. Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Deliv Rev 60:1226–1240.
   PubMed Web of Science ®Google Scholar
• So MK, Xu CJ, Loening AM, Gambhir SS, Rao JH. 2006. Self-illuminating quantum dot conjugates for in vivo imaging. Nature Biotechnol 24:339–343.
   PubMed Web of Science ®Google Scholar
• Tanimoto A, Yuasa Y, Shinmoto H, Jinzaki M, Imai Y, Okuda S, Kuribayashi S. 2002. Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: Pulse sequence effects and Kupffer cell function. Radiology 222:661–666.
   PubMedGoogle Scholar
• Thorek DLJ, Chen A, Czupryna J, Tsourkas A. 2006. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Engine 34:23–38.
   PubMed Web of Science ®Google Scholar
• Voura EB, Jaiswal JK, Mattoussi H, Simon SM. 2004. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nature Med 10:993–998.
   PubMed Web of Science ®Google Scholar
• Wang F, Liu XG. 2008. Upconversion multicolor fine-tuning: Visible to near-infrared emission from lanthanide-doped NaYF4 nanoparticles. J Am Chem Soc 130:5642–5643.
   PubMed Web of Science ®Google Scholar
• Yao HQ, Zhang Y, Xiao F, Xia ZY, Rao JH. 2007. Quantum dot/bioluminescence resonance energy transfer based highly sensitive detection of proteases. Angewandte Chem-Int Ed 46:4346–4349.
   PubMed Web of Science ®Google Scholar
• Yi GS, Lu HC, Zhao SY, Yue G, Yang WJ, Chen DP, Guo LH. 2004. Synthesis, characterization, and biological application of size-controlled nanocrystalline NaYF4: Yb,Er infrared-to-visible up-conversion phosphors. Nano Lett 4:2191–2196.
   Web of Science ®Google Scholar
• Young IR, Clarke GJ, Bailes DR, Pennock JM, Doyle FH, Bydder GM. 1981. Enhancement of relaxation rate with paramagnetic contrast agents in NMR imaging. J Comput Tomogr 5:543–547.
   PubMedGoogle Scholar
• Zijlmans H, Bonnet J, Burton J, Kardos K, Vail T, Niedbala RS, Tanke HJ. 1999. Detection of cell and tissue surface antigens using up-converting phosphors: A new reporter technology. Analyt Biochem 267:30–36.
   PubMed Web of Science ®Google Scholar